Inventor · disambiguated record
Austin B. Huang
Also filed as: HUANG AUSTIN B
7 granted patents·7 pending applications·33 citations·filing 2009–2025
85Inventor score
Top patents by PatentIndex Score
14 records- 0191US2025367208A1Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0289US9662338B2Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2016·Granted May 30, 2017·5 cites·14 claims
- 0389US8748472B2Stabilized formulations of CNS compoundsCHANG RONG-KUN·Filed 2011·Granted Jun 10, 2014·11 cites·44 claims
- 0488US10265319B2Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2017·Granted Apr 23, 2019·4 cites·20 claims
- 0588US9358204B2Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2013·Granted Jun 7, 2016·7 cites·13 claims
- 0687US2023381191A1Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0785US9603853B2Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2016·Granted Mar 28, 2017·3 cites·14 claims
- 0884US11077114B2Stabilized formulations of CNS compoundsSUPERNUS PHARMACEUTICALS INC·Filed 2018·Granted Aug 3, 2021·1 cites·28 claims
- 0982US2025222004A1Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1082US2025228859A1Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1177US10149853B2Stabilized formulations of CNS compoundsSUPERNUS PHARMACEUTICALS INC·Filed 2014·Granted Dec 11, 2018·2 cites·22 claims
- 1272US2021322429A1Stabilized formulations of cns compoundsSUPERNUS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1369US2019201407A1Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1451US2009304794A1Controlled release formulations of pramipexoleSUPERNUS PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Austin B. Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →